JP Morgan Chase
GDRX icon

JP Morgan Chase’s GoodRx Holdings GDRX Stock Holding History

JP Morgan Chase’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40,000
Closed -$186K – 7452
2024
Q4 		$186K Buy
+40,000
New +$220K ﹤0.01% 5505

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

JP Morgan Chase's GDRX Position: Q2 2026 in Review

JP Morgan Chase increased its GoodRx Holdings (GDRX) stake by 255% in Q2 2026, buying an estimated $6.48K and bringing the position to 3,549 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6914.

JP Morgan Chase first reported a position in GDRX in Q3 2020 and has held it in 24 quarters since. The position peaked at $49.5M in Q3 2020. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • JP Morgan Chase held 3,549 shares of GoodRx Holdings worth $10.1K as of Q2 2026.
  • JP Morgan Chase bought 2,549 GoodRx Holdings shares in Q2 2026, an estimated $6.48K.
  • GoodRx Holdings made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6914 holding.
  • JP Morgan Chase first reported a position in GoodRx Holdings in Q3 2020 and has held it in 24 quarters since.
  • JP Morgan Chase's GoodRx Holdings position peaked at $49.5M in Q3 2020.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.